Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Reigniting the Cannabis Oral Delivery System Marketplace

This podcast is part of our Cannabis Sector CEO interview series, and our mission going forward is to help listeners and investors understand more about investment opportunities in the public marketplace. Stockhouse Media's Dave Jackson was recently joined live with Bra...
Dave Jackson | September 23, 2019 |

IoT solutions company raises cleaning standards

The following is a transcription of the above video, and The Market Online Canada has edited it for clarity . Our next company is Visionstate Corp. (TSXV:VIS) , headquartered in Edmonton. The company is focused on delivering data-driven, innovative and sustainable ...
Ryan Dhillon | February 14, 2024 |

Vaxart Shares Rise 95% After Signing Agreement for Oral Tablet COVID-19 Vaccine

Shares of Vaxart Inc. nearly doubled after the company reported that it has signed a Memorandum of Understanding with Attwill Medical Solutions Sterilflow to enable production of a billion or more tablet COVID-19 vaccine doses annually. Clinical-stage biotechnology...
Streetwise Reports | June 26, 2020 |

Wanda Solution: The IoT and AI Evolution of Facility Management

(Image via Visionstate Corp.) There are plenty of unique opportunities for investors out there, but few are so unique that their platform has essentially no direct competition in the marketplace …. Headquartered in Edmonton, Alberta, Canada, Visionstate Cor...
Jonathon Brown | May 7, 2021 |

Introducing: The Device to Replace Antiquated Paper-Based Systems

(Image via Visionstate Corp. Click to enlarge.) The Internet of Things (IoT) describes the network of physical objects “things” that are embedded with sensors, software, and other technologies for the purpose of connecting and exchanging data ...
Featured Submission | March 1, 2022 |

Iterum Therapeutics Shares Double After Completing Enrollment in Phase 3 Antibiotic Trial

Iterum Therapeutics shares traded more than 100% higher after the company reported that it has completed enrollment in its Phase 3 SURE 1 clinical study of oral sulopenem for treatment of uncomplicated urinary tract infections. The firm expects to receive topline data results ...
Streetwise Reports | December 30, 2019 |

A True Disruptive Technology that Leverages the Power of Analytics

When Stockhouse Editorial first introduced our audience to Visionstate Corp. ( TSX-V: VIS , OTC: VSSSF , Forum ) back in May , we learned about a company so unique that their Internet of Things platform has, essentially, no direct competition in the marketplace. Vision...
Dave Jackson | January 14, 2022 |

The Hottest Startup Of 2020 Is Cleaning Up Your Commute

We've come a long way in a short time since ride-sharing emerged as a mainstream offering. Now, there's even an app that lets consumers participate in one of the biggest trends of the decade without leaving an environmental footprint. It's the app that does what Uber and ...
Joao Peixe | March 26, 2020 |

Myovant Sciences Shares Up 110% on Phase 3 Advanced Prostate Cancer Data

Shares of Myovant Sciences opened 120% higher today after the firm reported a 97% response rate in its Phase 3 HERO Study of oral Relugolix in men with advanced prostate cancer. In the study, Relugolix achieved all six key secondary endpoints and the firm expects to submit a N...
Streetwise Reports | November 20, 2019 |

Axsome Therapeutics Shares Open 82% Higher on Phase 3 MDD Trial Outcome

Axsome Therapeutics shares reached a new 52-week high price today after the company reported that its AXS-05 drug achieved primary endpoint in the GEMINI Phase 3 trial in Major Depressive Disorder. The firm indicated that the positive results support a New Drug Application fil...
Streetwise Reports | December 17, 2019 |
1 2 3 4 5 6 7 8 9 10 ...